Possible consequences of human antibody responses on the biodistribution of fragments of human, humanized or chimeric monoclonal antibodies: A note of caution
- 31 December 1994
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 55 (2), PL45-PL49
- https://doi.org/10.1016/0024-3205(94)90111-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Influence of a syngeneic anti-idiotypic antibody response to a mouse anti-tumour monoclonal antibody on biodistribution of its radiolabelled Fc-intact monovalent Fab/c fragmentNuclear Medicine and Biology, 1994
- Influence of syngeneic monoclonal anti-idiotypic antibodies to murine monoclonal antibodies against tumour-associated antigens on the biodistribution of their target antibodies and their fragmentsZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Human Antibody Response to the Intravenous and Intraperitoneal Administration of the F(ab')2 Fragment of the OC125 Murine Monoclonal AntibodyJournal of Immunotherapy, 1992
- Human IgM Monoclonal Antibody 16.88: Pharmacokinetics and Immunogenicity in Colorectal Cancer PatientsJNCI Journal of the National Cancer Institute, 1991
- By-passing immunizationJournal of Molecular Biology, 1991
- The minimal antigen-binding fragment of antibodies—Fv fragmentMolecular Immunology, 1991
- Phase I Study on Human Monoclonal Antibody Against CytomegalovirusJournal of Immunotherapy, 1991
- Syngeneic anti-idiotypic antibody prevents localization of a murine monoclonal antibody in human tumour xenograftsEuropean Journal of Cancer and Clinical Oncology, 1990
- The influence of syngeneic anti-idiotypic antibody on the biodistribution of an anti-tumour monoclonal antibody in balb/c miceInternational Journal of Cancer, 1989
- Human immunological response to mouse monoclonal antibodies in the treatment or diagnosis of malignant diseasesNuclear Medicine Communications, 1988